Fragile X and Related Autism Spectrum Disorders, Volume 172 in the International Review on Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on The dopamine hypothesis of Autism Spectrum Disorder: a comprehensive analysis of the evidence, A Review of the Use of Psychotropic Medication to Address Challenging Behavior in Neurodevelopmental Disorders, Lipid metabolism alterations in fragile X syndrome and other neurodevelopmental disorders, Genesis, modelling and methodological remedies to autism heterogeneity, Toward an Understanding of the Role of the Exposome on Fragile X Phenotypes, Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome, and more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Preface - p. iii 8. Chapter One: The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence - p. 1 9. Chapter Two: A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders - p. 42 10. Chapter Three: Involvement of brain metabolism in neurodevelopmental disorders - p. 67 11. Chapter Four: Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders - p. 115 12. Chapter Five: Toward an understanding of the role of the exposome on fragile X phenotypes - p. 141 13. Chapter Six: How dendritic spines shape is determined by MMP-9 activity in FXS - p. 171 14. Chapter Seven: Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome - p. 187
Fragile X and Related Autism Spectrum Disorders, Volume 172 in the International Review on Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters on The dopamine hypothesis of Autism Spectrum Disorder: a comprehensive analysis of the evidence, A Review of the Use of Psychotropic Medication to Address Challenging Behavior in Neurodevelopmental Disorders, Lipid metabolism alterations in fragile X syndrome and other neurodevelopmental disorders, Genesis, modelling and methodological remedies to autism heterogeneity, Toward an Understanding of the Role of the Exposome on Fragile X Phenotypes, Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome, and more.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iii 6. Contributors - p. iii 7. Preface - p. iii 8. Chapter One: The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence - p. 1 9. Chapter Two: A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders - p. 42 10. Chapter Three: Involvement of brain metabolism in neurodevelopmental disorders - p. 67 11. Chapter Four: Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders - p. 115 12. Chapter Five: Toward an understanding of the role of the exposome on fragile X phenotypes - p. 141 13. Chapter Six: How dendritic spines shape is determined by MMP-9 activity in FXS - p. 171 14. Chapter Seven: Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome - p. 187
